Abstract
Gengival hypertrophy has been associated with the use of several drugs (phenytoin, primidone, valproic acid, nifedipine, nicardipine et al). Recently also CyA has been reported to cause this side effect. The mechanisms by which CyA cause gengival hypertrophy are little known: it has been hypothesized that, like phenytoin, CyA may select a subpopulation of fibroblasts producing highlevels of collagen, which accumulates causing gengival hyperplasia Aim of this study is to see if the incidence and the severity of gengival hyperplasia was related to the CyA blood levels.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Rostock, Turnes. J. Periodontal 57: 294, 1986.
Tyldesley, Rotter, British Dental J. November 10, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Matarasso, S. et al. (1989). Relation Between Gengival Overgrowth and Cyclosporin (CyA) Blood Levels in Renal Transplanted Patients. In: Andreucci, V.E., Dal Canton, A. (eds) Current Therapy in Nephrology. Developments in Nephrology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0865-2_148
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0865-2_148
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8209-9
Online ISBN: 978-1-4613-0865-2
eBook Packages: Springer Book Archive